Locomotor hyperactivity induced by blockade of prefrontal cortical alpha2-adrenoceptors in monkeys

Biol Psychiatry. 2005 Jan 15;57(2):192-5. doi: 10.1016/j.biopsych.2004.11.004.

Abstract

Background: Stimulation of alpha(2)-adrenergic receptors (alpha(2)-ARs) in the prefrontal cortex (PFC) has a beneficial effect on working memory and attentional regulation in monkeys. alpha(2)-adrenergic agonists like clonidine and guanfacine have been used experimentally and clinically for the treatment of attention deficit and hyperactivity disorder (ADHD). However, it is unknown if alpha(2)-ARs in the PFC are involved in the neural mechanisms underlying regulation of locomotor activity.

Methods: The alpha(2)-adrenergic antagonist yohimbine was infused bilaterally and chronically into the dorsolateral PFC (dlPFC) in two monkeys, using mini-osmotic pumps. Spontaneous locomotor activity was measured continuously before, during and after drug administration, using an activity monitor.

Results: The monkeys exhibited a dramatic increase in motoric activity during infusion of yohimbine into the dlPFC. Similar treatment with saline was without effect. Thus, the locomotor hyperactivity was due to blockade of alpha(2)-ARs, not because of nonspecific factors such as cortical damage by drug administration.

Conclusions: The present study suggests that alpha(2)-ARs in the dlPFC are involved in inhibitory control of locomotor activity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenergic alpha-2 Receptor Antagonists*
  • Adrenergic alpha-Antagonists / administration & dosage
  • Animals
  • Drug Administration Schedule
  • Female
  • Hyperkinesis / chemically induced
  • Hyperkinesis / physiopathology*
  • Macaca mulatta
  • Microinjections
  • Motor Activity / drug effects
  • Motor Activity / physiology*
  • Prefrontal Cortex / drug effects*
  • Receptors, Adrenergic, alpha-2 / physiology*
  • Yohimbine / administration & dosage

Substances

  • Adrenergic alpha-2 Receptor Antagonists
  • Adrenergic alpha-Antagonists
  • Receptors, Adrenergic, alpha-2
  • Yohimbine